Genpact (G)
NYSE:G
Top Page
Genpact
(NYSE:G)
Select Model
Select Model
Rating:73Outperform
Price Target:
$45.00
▲(21.85% Upside)
Action:ReiteratedDate:02/07/26
The score is driven primarily by strong financial fundamentals (improving leverage, solid profitability and free cash flow) and a constructive earnings outlook with margin and EPS expansion guidance. These strengths are tempered by weak technicals (below key moving averages with negative MACD) despite oversold conditions, while a low P/E and moderate dividend yield provide additional support.
Positive Factors
Strengthened balance sheet / lower leverage
Material reduction in leverage to ~0.23x materially lowers financial risk and increases strategic optionality. A conservative capital structure supports investment in ATS and AI, sustains capital returns, and improves resilience to cyclical slowdowns over the next several quarters.
Negative Factors
Net-margin step-down
A persistent ~300bp decline in net margin reduces the company's ability to convert operating gains into bottom-line profits. If pressures below the operating line persist, earnings leverage from revenue growth and ATS expansion may be muted over coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Strengthened balance sheet / lower leverage
Material reduction in leverage to ~0.23x materially lowers financial risk and increases strategic optionality. A conservative capital structure supports investment in ATS and AI, sustains capital returns, and improves resilience to cyclical slowdowns over the next several quarters.
Read all positive factors
Genpact (G) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$6.27B
Dividend Yield1.41%
Average Volume (3M)2.09M
Price to Earnings (P/E)14.7
Beta (1Y)0.73
Revenue Growth7.40%
EPS Growth-14.45%
CountryUS
Employees145,000
SectorTechnology
Sector Strength88
IndustryInformation Technology Services
Share Statistics
EPS (TTM)0.97
Shares Outstanding169,762,710
10 Day Avg. Volume1,786,781
30 Day Avg. Volume2,088,936
Financial Highlights & Ratios
PEG Ratio1.41
Price to Book (P/B)3.19
Price to Sales (P/S)1.60
P/FCF Ratio11.07
Enterprise Value/Market Cap1.11
Enterprise Value/Revenue1.37
Enterprise Value/Gross Profit3.79
Enterprise Value/Ebitda8.07
Forecast
1Y Price Target
$46.17Price Target Upside25.02% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)4.02
Revenue Forecast (FY)$5.44B
Genpact Business Overview & Revenue Model
Company Description
Genpact Limited provides business process outsourcing and information technology (IT) services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Banking, Capital Markets and Insurance; Consumer Goods,...
How the Company Makes Money
Genpact generates revenue through a diversified model that includes multiple streams. Primarily, the company earns money by providing consulting and outsourcing services to clients, which encompasses business process outsourcing (BPO), IT services...
Genpact Key Performance Indicators (KPIs)
Any
Number of Clients Greater Than $25m Revenue
Indicates the number of major clients contributing significantly to revenue, highlighting reliance on large accounts and potential risks if any major client is lost.
Indicates the number of major clients contributing significantly to revenue, highlighting reliance on large accounts and potential risks if any major client is lost.
Data provided by:
The Fly
The FlyGenpact Earnings Call Summary
Earnings Call Date:Feb 05, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:May 13, 2026
Earnings Call Sentiment Positive
The call conveyed strong, broad-based progress: record revenue, significant acceleration in Advanced Technology Solutions (ATS), meaningful margin expansion, robust bookings and backlog, accelerating agentic (AgenTeq) traction, expanding product pipeline and partner momentum, and disciplined capital returns. Weaknesses were limited: softness in decision support services, modest consumer & healthcare growth, some reliance on a client prepayment for cash-flow benefit, variable large-deal timing, ongoing client productivity demands, and a higher effective tax rate. Overall, positives (growth, margin expansion, bookings, product/AI momentum) materially outweigh the listed challenges, and management provided constructive 2026 guidance.Positive Updates
Record Annual Revenue
Full-year 2025 revenue of $5.08 billion, up 6.6% year over year, marking a record year for Genpact.
Negative Updates
Softness in Decision Support Services
Core business services growth was partially offset by softness in decision support services in Q4, weighing on overall core segment momentum.
Read all updates
Q4-2025 Updates
Positive
Negative
Record Annual Revenue
Full-year 2025 revenue of $5.08 billion, up 6.6% year over year, marking a record year for Genpact.
Read all positive updates
Company Guidance
Genpact guided to at least 7% revenue growth for fiscal 2026 (as‑reported) with Advanced Technology Solutions accelerating to at least high‑teens growth, full‑year gross margin expanding ~50 basis points to 36.5% and adjusted operating income margin up ~25 basis points to 17.7%, driving ~10% growth in adjusted diluted EPS (outpacing revenue); management reiterated a balanced capital allocation approach targeting roughly 50% of operating cash flow returned to shareholders via buybacks/dividends and announced a 10% increase in the regular quarterly dividend, noted committed revenue near historical levels (~75%) and a record backlog, and provided Q1 targets of $1.282–$1.294 billion revenue (≈6% growth at midpoint), ATS accelerating to high‑teens, Q1 gross margin 36.3%, Q1 adjusted operating income margin 17.3% and adjusted diluted EPS of $0.92–$0.93.Genpact Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
83
Very Positive
Cash Flow
75
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.08B | 4.77B | 4.48B | 4.37B | 4.02B |
| Gross Profit | 1.81B | 1.69B | 1.57B | 1.54B | 1.43B |
| EBITDA | 874.70M | 852.58M | 772.52M | 652.86M | 709.01M |
| Net Income | 552.49M | 513.67M | 631.25M | 353.40M | 369.45M |
Balance Sheet | |||||
| Total Assets | 5.84B | 4.99B | 4.81B | 4.59B | 4.98B |
| Cash, Cash Equivalents and Short-Term Investments | 1.20B | 671.61M | 583.67M | 646.76M | 899.46M |
| Total Debt | 1.76B | 1.45B | 1.50B | 1.70B | 2.00B |
| Total Liabilities | 3.29B | 2.60B | 2.56B | 2.76B | 3.08B |
| Stockholders Equity | 2.55B | 2.39B | 2.25B | 1.83B | 1.90B |
Cash Flow | |||||
| Free Cash Flow | 734.65M | 530.19M | 432.04M | 389.28M | 637.03M |
| Operating Cash Flow | 812.86M | 615.42M | 490.81M | 443.67M | 694.28M |
| Investing Cash Flow | -495.50M | -105.96M | -78.94M | -36.59M | -122.75M |
| Financing Cash Flow | -106.81M | -424.85M | -483.00M | -571.40M | -332.88M |
Genpact Technical Analysis
Negative
36.93
Price Trends
38.99
Negative
42.44
Negative
42.35
Negative
Market Momentum
-0.63
Negative
39.12
Neutral
48.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For G, the sentiment is Negative. The current price of 36.93 is below the 20-day moving average (MA) of 37.80, below the 50-day MA of 38.99, and below the 200-day MA of 42.35, indicating a bearish trend. The MACD of -0.63 indicates Negative momentum. The RSI at 39.12 is Neutral, neither overbought nor oversold. The STOCH value of 48.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for G.
Genpact Risk Analysis
Genpact disclosed 43 risk factors in its most recent earnings report. Genpact reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Genpact Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $6.27B | 14.72 | 21.81% | 1.41% | 7.40% | -14.45% | |
72 Outperform | $4.78B | 27.23 | 25.50% | ― | 14.43% | 29.86% | |
68 Neutral | $7.04B | 30.32 | 10.27% | ― | 14.26% | -15.49% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | $2.15B | 6.07 | 13.41% | ― | -4.13% | 2143.48% | |
53 Neutral | $2.93B | 26.53 | 20.43% | ― | -1.90% | ― |
* Technology Sector Average
G
Genpact
36.93
-9.02
-19.62%
EPAM
Epam Systems
129.99
-16.30
-11.14%
EXLS
Exlservice Holdings
30.55
-13.47
-30.60%
DXC
DXC Technology
12.69
-1.56
-10.95%
KD
Kyndryl Holdings Incorporation
12.99
-16.10
-55.35%
Genpact Corporate Events
Business Operations and StrategyPrivate Placements and Financing
Genpact Completes $350 Million Senior Notes Offering
Neutral
Nov 18, 2025
On November 18, 2025, Genpact UK Finco plc and Genpact USA, Inc., subsidiaries of Genpact Limited, completed a $350 million public offering of 4.950% Senior Notes due 2030. The notes are guaranteed by Genpact and Genpact Luxembourg and are intende...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.